The ESCAPE study: offering smoking cessation treatment as part of routine psychological care

Conditions

Tobacco addiction (smoking) Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco

Gemma Taylor, Katherine Sawyer, Pamela Jacobsen, Tom P. Freeman, Anna Blackwell et al. (10 authors)

Addiction2025-03-112 citations

Service‐user experiences of an integrated psychological intervention for depression or anxiety and tobacco smoking in improving access to psychological therapies services: A qualitative investigation into mechanisms of change in quitting smoking

Kim Fredman Stein, Katherine Sawyer, Shadi Daryan, Jennifer L. Allen, Gemma Taylor

Health Expectations2022-12-0815 citations

10.1111/hex.13684

IntEgrating Smoking Cessation treatment As part of usual Psychological care for dEpression and anxiety (ESCAPE): protocol for a randomised and controlled, multicentre, acceptability, feasibility and implementation trial.

Taylor G, Aveyard P, Bartlem K, Shaw A, Player J, Metcalfe C, Kessler D, Munafò M.

2019-01-2210 citations

10.1186/s40814-018-0385-2

Interventions

The randomisation sequence will be generated using computer software, RedCap (i.e., an online central randomisation service provided by Bristol Medical School). Randomisation will be stratified by sit

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older 2. Has current diagnosis of depression (clinician administered PHQ-9 score of = 10) and/or anxiety (clinician administered GAD-7 score of =8) (note: other mental health comorbidities are allowable) 3. Self-reported, daily tobacco smoker of at least 1 year 4. Interested in receiving help to quit smoking tobacco 5. Eligible for IAPT treatment on a one-to-one basis over the telephone or face-to-face 6. About to start psychological therapy for depression/anxiety in IAPT

Exclusion criteria

Exclusion criteria: 1. Already started IAPT treatment 2. Considered too unwell by research or clinical team (i.e. the IAPT provider) 3. Pregnant or breastfeeding

Design outcomes

Primary

Measure	Time frame
Retention in the smoking cessation treatment, measured at treatment appointments 1 to 6	—

Secondary

Measure	Time frame
Current secondary outcome measures as of 08/02/2021: Smoking-related: 1. Biochemically-verified 7-day point prevalence smoking cessation at 3 and 6 months after baseline 2. Number of cigarettes smoked per day, measured at enrolment, treatment appointments 1 to 6, and 3 and 6 months after baseline 3. Heaviness of Smoking Index, measured at enrolment, treatment appointments 1 to 6, and 3 and 6 months after baseline Mental health-related: 1. Symptoms of depression, measured using the Patient Health Questionnaire-9 (PHQ-9) at baseline, treatment appointments 1 to 6, and 3 and 6 months after baseline 2. Symptoms of anxiety, measured with General Anxiety Disorder-7 (GAD-7) questionnaire at baseline, treatment appointments 1 to 6, and 3 and 6 months after baseline Service-related: 1. Number of “Did Not Attends”, number of planned and completed IAPT sessions, measured at treatment appointments 1 to 6 Acceptability and feasibility 1. Participant and clinician acceptability and satisfaction of intervention as assessed by questionnaires and qualitative interviews at 3 months after baseline. Interviews also explore the acceptability and feasibility of data collection procedures and the impact of smoking cessation treatment on usual care and psychological recovery. Implementation-related 1. Intervention delivery checklist and qualitative analysis of intervention delivery measured at treatment appointments 1 to 6 Secondary outcome measures as of 03/10/2019: Smoking-related: 1. Biochemically-verified 7-day point prevalence smoking cessation at 3 and 6 months after baseline 2. Number of cigarettes smoked per day, measured at enrolment, treatment appointments 1 to 6, and 3 and 6 months after baseline 3. Heaviness of Smoking Index, measured at enrolment, treatment appointments 1 to 6, and 3 and 6 months after baseline Mental health-related: Symptoms of depression, measured using PHQ-9 Service-related: Number of “Did Not Attends”, number of planned and completed IAPT session	—

Measure

Time frame

Current secondary outcome measures as of 08/02/2021: Smoking-related: 1. Biochemically-verified 7-day point prevalence smoking cessation at 3 and 6 months after baseline 2. Number of cigarettes smoked per day, measured at enrolment, treatment appointments 1 to 6, and 3 and 6 months after baseline 3. Heaviness of Smoking Index, measured at enrolment, treatment appointments 1 to 6, and 3 and 6 months after baseline Mental health-related: 1. Symptoms of depression, measured using the Patient Health Questionnaire-9 (PHQ-9) at baseline, treatment appointments 1 to 6, and 3 and 6 months after baseline 2. Symptoms of anxiety, measured with General Anxiety Disorder-7 (GAD-7) questionnaire at baseline, treatment appointments 1 to 6, and 3 and 6 months after baseline Service-related: 1. Number of “Did Not Attends”, number of planned and completed IAPT sessions, measured at treatment appointments 1 to 6 Acceptability and feasibility 1. Participant and clinician acceptability and satisfaction of intervention as assessed by questionnaires and qualitative interviews at 3 months after baseline. Interviews also explore the acceptability and feasibility of data collection procedures and the impact of smoking cessation treatment on usual care and psychological recovery. Implementation-related 1. Intervention delivery checklist and qualitative analysis of intervention delivery measured at treatment appointments 1 to 6 Secondary outcome measures as of 03/10/2019: Smoking-related: 1. Biochemically-verified 7-day point prevalence smoking cessation at 3 and 6 months after baseline 2. Number of cigarettes smoked per day, measured at enrolment, treatment appointments 1 to 6, and 3 and 6 months after baseline 3. Heaviness of Smoking Index, measured at enrolment, treatment appointments 1 to 6, and 3 and 6 months after baseline Mental health-related: Symptoms of depression, measured using PHQ-9 Service-related: Number of “Did Not Attends”, number of planned and completed IAPT session

—

Countries

England, United Kingdom

Contacts

Public ContactGemma Taylor

g.m.j.taylor@bath.ac.uk+44 (0)1225 383379

Outcome results

None listed